We’re tracking in-house compensation. Take the Law360 Survey
Click here
Eisai Inc v. Sanofi Aventis U.S. LLC, et al
-
June 08, 2016
The Third Circuit on Wednesday denied a bid by pharmaceutical company Eisai Inc. to have the full court revisit a panel's earlier decision not to revive an antitrust suit against Sanofi-Aventis U.S. LLC over the anticoagulant Lovenox.
-
May 19, 2016
Pharmaceutical company Eisai asked the full Third Circuit on Wednesday to revisit the company's bid to revive an antitrust suit against Sanofi, arguing that the panel set a harmful precedent for consumers by allowing Sanofi to enter arrangements with hospitals that effectively excluded competition for the anticoagulant Lovenox.
-
January 13, 2015
Pharmaceutical manufacturer Eisai Inc. on Tuesday asked the Third Circuit to reinstate its antitrust lawsuit against Sanofi-Aventis U.S. LLC over discount contracts with hospitals that purchased large amounts of its anticoagulant drug Lovenox, arguing the company improperly worked to raise the price of competitors.